Expert Answer
Quick Answer
Yes. GLP-1s raise resting heart rate by a consistent 8-12 bpm and compress heart-rate variability (HRV), per Attia and HRV specialist Joel Jamieson. Both typically normalize within about a month of stopping. It is likely vagus-nerve mediated and worth weighing if you are using one cosmetically or tracking cardiovascular fitness.
Moderate Consensus
on GLP-1 Agonists overall
In a dedicated explainer, describes a consistent 8-12 bpm rise in resting heart rate and HRV compression that normalize within about a month of discontinuation.
This is one of the more measurable and under-discussed effects of GLP-1 drugs, and Attia has covered it in a dedicated explainer. The finding: resting heart rate rises by a consistent 8-12 bpm, and heart-rate variability (HRV) — a marker of autonomic balance and recovery — gets compressed.
The mechanism is likely vagus-nerve mediated rather than a sign of cardiovascular damage, and the effect is reversible: both resting heart rate and HRV typically normalize within about a month of discontinuing the drug. HRV specialist Joel Jamieson (via Attia) independently reports the same 8-12 bpm increase and HRV compression, and raises the longer-term question of what sustained sympathetic "overdrive" costs someone using the drug for years.
Why it matters in practice: if you wear a recovery tracker, expect your readiness/HRV scores to look worse on a GLP-1 — that is the drug, not necessarily your fitness. And for someone using a GLP-1 cosmetically (to lose a modest amount of weight) rather than to treat obesity or diabetes, the resting-heart-rate cost is a real part of the trade-off worth discussing with a physician. Note this is distinct from the drugs' established cardiovascular-event benefit in higher-risk patients — heart rate up in the short term, major cardiac events down over the long term are not contradictory.
By a consistent 8-12 bpm at rest, with compressed HRV, per Attia and Joel Jamieson. It typically normalizes within about a month of stopping the drug.
It is likely vagus-nerve mediated and reversible, not a sign of damage. But Jamieson flags the open question of sustained sympathetic drive over years — discuss with your physician.
GLP-1s compress HRV alongside the resting-heart-rate rise, so recovery-tracker scores look worse. That reflects the drug's autonomic effect, not necessarily your fitness.
This page covers what researchers agree on. Pro gives you the specific dosages, timing schedules, and interaction warnings they each recommend — with video citations you can verify.
Cancel anytime
Full GLP-1 Agonists Consensus Report
See what all the experts agree and disagree on